POINT–COUNTERPOINT: What is the optimal trial design to test hyperthermia for carcinoma of the cervix? POINT: Addition of hyperthermia or cisplatin to radiotherapy for patients with cervical cancer; two promising combinations—no definite conclusions

Author: Van Der Zee J.   Koper P. C. M.   Lutgens L. C. H. W.   Burger C. W.  

Publisher: Informa Healthcare

ISSN: 1464-5157

Source: International Journal of Hyperthermia, Vol.18, Iss.1, 2002-01, pp. : 19-24

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content